Seon-Wook Hwang
Amministratore Delegato presso NOVMETAPHARMA CO., LTD.
Patrimonio netto: 17 M $ in data 31/07/2023
Profilo
Seon-Wook Hwang is currently the President, Co-Chief Executive Officer & Director at NovMetaPharma Co., Ltd.
He is also the Chief Executive Officer at PNC Holdings Co. Ltd.
and NovMetaHealth Co. Ltd.
Mr. Hwang completed his undergraduate and graduate degrees at Chung-Ang University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
NOVMETAPHARMA CO., LTD.
9.36% | 30/06/2023 | 1 038 030 ( 9.36% ) | 17 M $ | 31/07/2023 |
Posizioni attive di Seon-Wook Hwang
| Società | Posizione | Inizio |
|---|---|---|
| NOVMETAPHARMA CO., LTD. | Amministratore Delegato | 04/11/2010 |
NovMetaHealth Co. Ltd.
 NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Amministratore Delegato | 01/03/2016 |
| PNC Holdings Co. Ltd. | Amministratore Delegato | 01/09/2015 |
Formazione di Seon-Wook Hwang
| Chung-Ang University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
| NovMetaPharma Co., Ltd. | |
NovMetaHealth Co. Ltd.
NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Health Technology |
| PNC Holdings Co. Ltd. |
- Borsa valori
- Insiders
- Seon-Wook Hwang
